GRAS

A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference

Retrieved on: 
Freitag, Juni 14, 2024
Immunity, UHM, Thermostabilization, Excipient, Comparison, Thermostability, Water, ASM, University, Public health, Society, GRAS, Messenger, Conference, Post-exposure prophylaxis, Vaccine

PRINCETON, N.J., June 14, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Professor Axel Lehrer, University of Hawaiʽi at Mānoa (UHM), will be presenting key data from the Company's thermostable vaccine technology platform developed in collaboration with UHM, including results from the filovirus vaccine candidates for both Sudan ebolavirus (SuVax™) and Marburg marburgvirus (MarVax™). The presentation will be given at the upcoming American Society of Microbiology (ASM) Microbe Conference, Atlanta, Georgia, USA, June 13-17, 2024. The presentation will be followed by a panel discussion comparing advanced vaccine technologies and their advantages and disadvantages.

Key Points: 
  • The presentation will be given at the upcoming American Society of Microbiology (ASM) Microbe Conference, Atlanta, Georgia, USA, June 13-17, 2024.
  • The presentation will be followed by a panel discussion comparing advanced vaccine technologies and their advantages and disadvantages.
  • Oral Presentation / Panel Discussion:
    Session Title: Immune Responses to Viral Vaccine Platforms: Comparison of Live, mRNA, and Protein Subunit Vaccines on June 17, 2024 from 8:15-10:15 am.
  • Soligenix has recently been granted Orphan Drug Designation for the prevention and post-exposure prophylaxis against both Sudan ebolavirus and Marburg marburgvirus .

Steakholder Foods Signs Commercial Cooperation agreement with Wyler Farm

Retrieved on: 
Montag, Mai 13, 2024
3D, Meat, FPL, Fats, DLS, Food safety, GRAS, Safety, Sale, Beefsteak, Premix

REHOVOT, Israel, May 13, 2024 /PRNewswire/ -- Steakholder Foods Ltd. (Nasdaq: STKH), a leading innovator in alternative proteins and 3D printing technologies, announced a royalties and raw materials supply agreement with Wyler Farm Ltd., a leader in alternative protein production, whereby Wyler Farm will manufacture alternative proteins on a commercial scale using Steakholder Foods' premixes and know-how, in return for the payment of royalties from sales. The agreement is expected to generate the company's first commercial revenue, and marks Steakholder Foods' early transition from R&D to commercialization.

Key Points: 
  • The agreement is expected to generate the company's first commercial revenue, and marks Steakholder Foods' early transition from R&D to commercialization.
  • Steakholder Foods and Wyler Farm are continuing their negotiation to reach a second-stage follow-on agreement, in which Wyler Farm would produce plant-based 3D-printed meat products utilizing Steakholder Foods' proprietary 3D printing technology and premix blends, including producing Steakholder Foods' flagship Printed Beef Steak product.
  • Oleg Kulyava, CEO of Wyler Farm said: "Our agreement with Steakholder Foods enables us to significantly broaden our alternative protein product portfolio, reinforcing our goal of producing a broad spectrum of high-quality, plant-based foods.
  • We expect our adoption of Steakholder Foods' technologies will propel Wyler Farm to be a leading brand in the plant-based alternative meat sector."

RYAM Announces Improved First Quarter 2024 Results

Retrieved on: 
Dienstag, Mai 7, 2024
Chemicals, Plastics, Retail, Alternative Energy, Energy, Manufacturing, Alternative Vehicles, Fuels, Pharmaceutical, Forest Products, Agriculture, Natural Resources, Other Manufacturing, Automotive, Food, Beverage, Packaging, Health, Corporation, Sale, Paperboard, Average cost, Cellulose, GRAS, ERP, Conference, Public expenditure, Operating cost, Adjustment, Nutritional science, USDOC, Fine chemical

Operating results improved $70 million primarily due to the $62 million non-cash asset impairment recorded in the fourth quarter.

Key Points: 
  • Operating results improved $70 million primarily due to the $62 million non-cash asset impairment recorded in the fourth quarter.
  • Included in non-operating other income in the quarter ended March 30, 2024 was a $1 million impact from favorable foreign exchange rates in the current quarter.
  • EBITDA is expected to decrease in the second quarter of 2024 compared to the first quarter of 2024 due to the annual planned maintenance outage at Jesup, but stronger than the second quarter of 2023.
  • Paperboard prices in 2024 are expected to remain relatively stable compared to the first quarter of 2024, while sales volumes are expected to improve due to improved customer demand.

Solarea Bio Announces the Beta Launch of Bondia™, a Novel Daily Medical Food Helping Menopausal Women Manage Bone Loss

Retrieved on: 
Mittwoch, Mai 8, 2024
Mortality, Inflammation, Cell, Woman, Osteoclast, Health, GRAS, Partnership, Doctor of Philosophy, DEXA, Osteoporosis, Physician, BMD, Peri, Fruit, Quality of life, Menopause, Dietary supplement

BOSTON, May 8, 2024 /PRNewswire/ -- All peri- and postmenopausal women experience bone loss, which can lead to osteoporosis if left unmanaged. And although osteoporosis is exceedingly common, afflicting 1 in 3 women, most are unaware of their condition and the implications that it can have for their health. An osteoporotic injury can be devastating, significantly reducing quality of life and—in the worst cases—resulting in a 30% mortality rate in the first-year post-hip fracture.

Key Points: 
  • BOSTON, May 8, 2024 /PRNewswire/ -- All peri- and postmenopausal women experience bone loss, which can lead to osteoporosis if left unmanaged.
  • Initially debuting via a private beta program, their first-ever product, Bondia™ medical food, is a daily synbiotic capsule that helps address bone loss in peri- and postmenopausal women.
  • Bondia™ medical food is Journa's naturally developed, clinical solution to manage postmenopausal bone loss.
  • In preparation for its private beta program, Bondia™ medical food is currently undergoing a double-blind, placebo-controlled clinical food trial in 286 early postmenopausal women.

Korea Ginseng Corporation Held a Dedicated International Seminar at the International Conference on the Science of Botanicals (ICSB) About Korean Red Ginseng in the United States

Retrieved on: 
Dienstag, April 30, 2024
Science, FDA, Food, Deficit spending, Food safety, Brain, Inflammation, KGC, Conference, China Medical University, Pharmacy, National Science Foundation, Konkuk University, Chili pepper, Safety, NIH, Hospital, Health, Research, Taste, USDA, Fatigue, Alzheimer's disease, Risk assessment, Medical school, GRAS, University, NSF, Patient, Immunity, Dietary supplement

CERRITOS, Calif., April 30, 2024 /PRNewswire/ -- Korea Ginseng Corp. US (KGCUS) aka JungKwanJang held a dedicated international seminar session on "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights'' at the International Conference on the Science of Botanicals (ICSB) hosted by the National Center for Natural Products Research (NCNPR). The conference is held annually at the Oxford Conference Center in Mississippi to bring together international leaders in the research, development, testing, regulation, and commercialization of botanical ingredients used for human health. From April 15th to 18th, approximately 400 attendees including government officials from the U.S. Food and Drug Administration (FDA), the U.S. Department of Agriculture (USDA), the National Science Foundation (NSF), and the National Institute of Health (NIH), university professors, researchers, and buyers partook in ICSB this year. 

Key Points: 
  • US (KGCUS) aka JungKwanJang held a dedicated international seminar session on "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights'' at the International Conference on the Science of Botanicals (ICSB) hosted by the National Center for Natural Products Research (NCNPR).
  • Through the seminars, attendees were able to gain insight into the safety and the significant benefits of Korean red ginseng.
  • The "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights" seminar consisted of presentations of scientifically proven research on the various efficacies of Korean red ginseng, where researchers from Korea, the United States, and Taiwan presented their results.
  • The company, Korean Ginseng Corporation, has conducted animal toxicity testing and numerous clinical trials with their red ginseng extract.

CleanCore Solutions Applauds Recent Bans and Restrictions on PFAS ‘Forever Chemicals’

Retrieved on: 
Donnerstag, Mai 2, 2024
Public, Coronavirus, PFAS, Prostate, EPA, Kidney, Pregnancy, Risk, Cancer, Food, Health, Bacteria, GRAS, Fertility, Ozone, Water, Environment, Obesity, GxP, Listeria, Virus, Puberty, Hepatitis, Infection, Salmonella, Green

Omaha, NE, May 02, 2024 (GLOBE NEWSWIRE) -- CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), a leading provider of EPA Green Seal® certified cleaning solutions including its patented aqueous ozone technology, proudly announces its support for the recent ban and new restrictions set by the U.S. Environmental Protection Agency (EPA) on the use of Per- and Polyfluorinated Substances (PFAS), also known as “forever chemicals.” The Company welcomes this critical rule finalized by the Biden-Harris administration, which designates Forever Chemicals as hazardous substances and sets new workplace safety requirements, marking a significant milestone in protecting public health and the environment.

Key Points: 
  • Forever chemicals have posed a persistent threat to ecosystems and human health due to their non-biodegradable nature and widespread use in various industrial and consumer products.
  • In contrast, CleanCore’s aqueous ozone is compliant with the EPA Organic Program as a natural and effective cleaner and sanitizer.
  • "As a pioneer in eco-friendly cleaning solutions, Cleancore Solutions has long been committed to providing products that not only meet high-performance standards for its clients but also are safe, environmentally responsible and adhere to all regulations," said Doug Moore, Chief Executive Officer of CleanCore.
  • As a result, we are witnessing unprecedented interest and demand from both corporations and consumers,” concluded Moore.

Yeast Fuel, Developed by Chula's Faculty of Science Soon to Expand Its Production for the Aerospace Industry

Retrieved on: 
Dienstag, April 23, 2024
Cell, Cosmetics, Beer, Biomass, Culture, Chulalongkorn University, Food, Medicine, Petroleum, Soil, PTT Public Company Limited, Acetyl-CoA carboxylase, Plant, TBI, Biotechnology, GIEC, Hamburg University of Technology, University of Hamburg, Biological engineering, Safety, Health, Heat, Research, Transport, TUHH, Carbon, Dicarboxylic acid, Energy transformation, Human, Pressure, Faculty, Temperature, Bread, Acetyl-CoA, National Research Council, GRAS, Genetic engineering, Environment, Ministry, Aircraft, Fermentation, Drink, Growth, Air pollution

BANGKOK, April 23, 2024 /PRNewswire/ -- Yeast is a microorganism that is an important ingredient in many foods and beverages. However, in the future, yeast will play a major role in the production of fossil-based renewable fuels. 

Key Points: 
  • They aim to expand petroleum-based oil replacement production to reduce impacts on human health and the environment.
  • However, in the future, yeast will play a major role in the production of fossil-based renewable fuels.
  • Currently, researchers from Chulalongkorn University's Faculty of Science are accelerating their technological development to scale up the production of aviation biofuel from yeast.
  • Petroleum is an important source of fuel in today's world, both in various industrial sectors and in transportation, especially the aircraft industry.

POM Wonderful Adds Pomegranate Fiber to its Specialty Ingredients Lineup

Retrieved on: 
Mittwoch, März 13, 2024
Electricity, Climate change, POM Wonderful, Innovation, Polyphenol, Pressure, POM, Pomegranate juice, Pomegranate, Browning, The Wonderful Company, Research, Food, RPET, Certification, GRAS, Renewable energy

1 pomegranate juice in North America, announced the addition of Pomegranate Fiber to its growing specialty ingredients lineup.

Key Points: 
  • 1 pomegranate juice in North America, announced the addition of Pomegranate Fiber to its growing specialty ingredients lineup.
  • The Pomegranate Fiber, which is upcycled from POM Wonderful pomegranate husks after juicing, is a GRAS , fiber-dense powder that can be used in a variety of food applications, including crackers, sauces, dressings, baked goods and plant-based food.
  • Pomegranate Fiber is made under POM Wonderful’s growing Specialty Ingredients division , which provides raw ingredients to suppliers across the food and beverage industry.
  • “We are thrilled to add another specialty ingredient to our line-up that is versatile and upholds our commitment to nourishing naturally,” said Jason Horvath, sales manager for POM Wonderful Specialty Ingredients.

Oobli Becomes First Company to Receive FDA "No Questions" Letter for a Novel Sweet Protein Produced via Precision Fermentation

Retrieved on: 
Mittwoch, März 20, 2024
Dark, Conference, Letter, Stevia, Milk, Insulin, Erythritol, Biomolecular engineering, University, Food, Protein, GRAS, African, Drink, Future, FDA, University of California, Berkeley, Dietary supplement

DAVIS, Calif., March 20, 2024 /PRNewswire/ -- Oobli, the leading global sweet protein platform known for its healthy sugar alternatives, today announced it has received the "No questions" letter from the US Food & Drug Administration (FDA), accepting the Company's conclusion that the Oubli Fruit Sweet Protein (known by its scientific name as "brazzein") is Generally Recognized as Safe (GRAS) for use as a sweetener in food and beverages. 

Key Points: 
  • "The Oubli Fruit Sweet Protein is one of several sweet proteins that is derived from fruits primarily found in West Africa and other equatorial environments.
  • Oobli is the first company to receive the "No questions" letter from the FDA for use of the Oubli Fruit Sweet Protein as a food ingredient.
  • "The Oubli Fruit Sweet Protein can be safely used in various foods with support from the general scientific community and the FDA.
  • Oobli will sample its line of craft-brewed, low-sugar Sweet Teas, as well as its Dark and Milk Chocolates featuring the Oubli Fruit Sweet Protein, at the Future Food-Tech Conference in San Francisco from March 21-22.

Superbrewed Food is the World’s First Company to Receive U.S. FDA No-Questions for Bacteria Biomass Protein and to Progress in Global Jurisdictions

Retrieved on: 
Mittwoch, März 6, 2024
Professional Services, Patent Law, Retail, Health, FDA, Venture Capital, Food, Beverage, IMAGE, EFSA, Multimedia, Zinc, Generally recognized as safe, Temperature, European, Partnership, Vitamin, Animal, GRAS, Letter, Probiotic, Sport, QPS, Human, Drink, Patent, Bel Group, Nutritional science, Credit, Environment, Iron, Dietary supplement

View the full release here: https://www.businesswire.com/news/home/20240306922266/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240306922266/en/
    Superbrewed Food Postbiotic Cultured Protein and Beverage made with Postbiotic Cultured Protein.
  • GRAS is a designation created by the FDA under the Federal Food, Drug and Cosmetic Act.
  • Superbrewed has filed applications for market authorization of Postbiotic Cultured Protein as a “novel food” in the European Union, Great Britain and Canada.
  • Postbiotic Cultured Protein is over 85% protein, with a high content of essential and branched-chain amino acids.